Physical Therapists in Ste Genevieve, MO Accepting Medicare
5 Physical Therapists found. Showing 1 - 5
 Dr. Hayley Pardoe, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 23001 Buckingham, Ste Genevieve, MO 63670 Phone: 573-883-6927 |
Mrs. Lynnette Marie Suiter, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 13737 Hilltop Dr, Ste Genevieve, MO 63670 Phone: 573-483-2606 |
Mrs. Maria S Rottler, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1010 Ste Genevieve Dr, Ste Genevieve, MO 63670 Phone: 573-883-5725 |
Mrs. Janet Carron Loida, R.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 599 Cedar Ln, Ste Genevieve, MO 63670 Phone: 573-883-3780 Fax: 573-883-3870 |
 Tyler Richmond Brown, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 60 Plaza Dr, Ste Genevieve, MO 63670 Phone: 573-608-5058 Fax: 844-912-8618 |
News Archive
Culprit in 'popcorn lung' identified
Scientists have pinpointed an ingredient in microwaved popcorn that could be the culprit in cases of "popcorn lung", a disease which affects people who work in the popcorn making industry.
EVERYAWARE develops AirProbe and Widenoise apps to increase awareness of environment
Air and noise pollution are among the most insidious threats to our health. But what if we could monitor both from our smartphones? The AirProbe and Widenoise apps, developed by an EU-funded research project called EVERYAWARE, have made this possible.
Certain uses of terbutaline could lead to maternal heart problems and death, FDA warns
The U.S. Food and Drug Administration is warning that terbutaline administered by injection or through an infusion pump should not be used in pregnant women for prevention or prolonged (beyond 48-72 hours) treatment of preterm labor due to the potential for serious maternal heart problems and death. In addition, oral terbutaline tablets should not be used for prevention or treatment of preterm labor.
AMRI announces acquisition of Hyaluron
AMRI today announced the acquisition of Hyaluron Inc., expanding AMRI's contract manufacturing capabilities to include cGMP manufacturing and sterile filling of parenteral drugs to the biopharmaceutical industry. AMRI has acquired all facilities and equipment as well as a highly trained and experienced staff of professionals with expertise in sterile GMP manufacturing. Purchase price, including debt, was approximately $27 million.
› Verified 7 days ago
Optometrists
Speech-Language Pathologists
Chiropractors
Physical Therapists
Occupational Therapists